SCHEMBL6854847

SCHEMBL6854847

CO[C@H]1C[C@]2(C)[C@@H](O)CC[C@H]2[C@@H]2CCc3cc(O)ccc3[C@H]21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 14/20 0.64
ESR2 Q92731 9/20 0.64
HSD17B10 Q99714 5/20 0.61
LMNA P02545 3/20 0.61
TSHR P16473 3/20 0.61
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61
CYP1A2 P05177 1/20 0.61
CYP2C9 P11712 1/20 0.61
CYP2C19 P33261 1/20 0.61
HIF1A Q16665 1/20 0.61
SLC22A1 O15245 1/20 0.61
AKR1B10 O60218 1/20 0.61
SLC22A3 O75751 1/20 0.61
ABCB11 O95342 1/20 0.61
ESRRB O95718 1/20 0.61
ALDH1A1 P00352 1/20 0.61
NR3C1 P04150 1/20 0.61
SHBG P04278 1/20 0.61
PGR P06401 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6854850 1.00 ESR1 (0.64) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL9144315 1.00 ESR1 (0.64) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL24399389 0.88 ESR1 (0.61) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL20010697 0.88 ESR1 (0.61) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL20015657 0.88 ESR1 (0.61) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL6541316 0.87 HSD17B10 (0.69) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL6541320 0.87 HSD17B10 (0.69) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL19644037 0.86 ESR1 (0.60) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL19644038 0.86 ESR1 (0.60) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL22368047 0.86 ESR1 (0.69) ESR1ESR2HSD17B10LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040002052-A1 Systems and methods for rapid evaluation and design of molecules for predicted biological activity PHARMACOGENETICS DEVELOPMENT COMPANY, INC. 2004-01-01 US disclosed
EP-0001668-B1 CYCLISATION PROCESS FOR PREPARING 11 BETA-AXIALLY-SUBSTITUTED STEROIDS AKZO N.V. (NL) 1983-05-25 EP disclosed
US-4222940-A Cyclization substrates, cyclization process and related 11β-axially-substituted steroids AKZONA INCORPORATED (US) 1980-09-16 US disclosed